Equity search
Top stocks
Moje portfolio
Set Favorites, set Portfolio
Oblíbené tituly
select
NameBest
buy		Best
sell		Change
(%)
ČEZ0.00
KB0.00
PKN71.9471.952.98
Msft0.13
Nokia4.374.520.65
IBM-1.94
Mercedes-Benz Group AG50.9350.950.39
PFE-3.00
10/05/2025 02:04:00
Real-Time data
Indices online
Nasdaq
Further equity indices

AD index online
select
AD index online
Patria Direct
Patria DirectThings our clients appreciate most: A large and experienced team of professional brokers, customer care support, stable and secure trading platform, unique news and information service. Try our demo account and see for yourself.

Free services: Patria Plus news services, analytical reports, account opening and keeping, submitting and cancelling orders, FX conversions. Moreover, for active traders we also offer free real-time data and Investor Plus services.
 

  • 09/05/2025
Rigel Pharm Rg (NASDAQ Cons)
Close at 9.5.2025 Change (%) Change (USD) Turnover (pcs)
18.77 -0.69 -0.13 250,170
R - Real-Time data can be activated by Patria Plus / Investor Plus clients HERE.

Actions
Buy / Sell - Trial portfolio
Add to my favorites
Set SMS / E-Mail alert
Analytical service
Historical data
 
  • Účetní období do: 31/03/2025
Next Economy Results
Market capitalization 337.79 mil. USD Hrubá marže (12M klouzavě) 89.64%
Celkové tržby (12M klouzavě) 203.08 mil. USD Návratnost vlastního jmění (ROE, 12M klouzavě) -
EBITDA (12M klouzavě) 46.36 mil. USD Cena/tržby na akcii (12M klouzavě) 1.66
Čistý zisk pro akcionáře (12M klouzavě) 37.18 mil. USD P/E bez mimořádných položek (12M klouzavě) 9.11
Zisk na akcii (EPS, 12M klouzavě) 2.07 P/BV (poslední čtvrtletí) 18.19
Tržby na akcii (12M klouzavě) 11.39 Enterprise Value 320.44 mil. USD
Účetní hodnota na akcii (BV, poslední čtvrtletí) 1.04 Cash-flow na akcii (12M klouzavě) 2.22
Hotovost na akcii (poslední čtvrtletí) 4.32 Dividenda na akcii (12M klouzavě) 0.00
Source: Reuters
Currency: USD
On mouse over for description.
  • Latest update: 10/05/2025
Financial results 
select
select
Submit
 2024/12024/22024/32024/42025/1
Cash & Equivalents2636525746
Short Term Investments241392131
Cash and Short Term Investments5049617777
Accounts Receivable - Trade, Net2829314242
Total Receivables, Net2829314242
Total Inventory78565
Prepaid Expenses99101023
Total Current Assets9295106135147
Property/Plant/Equipment, Total - Net11101
Intangibles, Net2928282727
Other Long Term Assets, Total45512
Total Assets127128139164176
Accounts Payable96434
Accrued Expenses1618222519
Notes Payable/Short Term Debt00000
Current Port. of LT Debt/Capital Leases150-715
Other Current Liabilities, Total3435292829
Total Current Liabilities7359546367
Long Term Debt4560605245
Total Long Term Debt4560605245
Total Debt6060606060
Other Liabilities, Total4040404546
Total Liabilities158158154161157
Preferred Stock - Non Redeemable, Net0----
Common Stock00000
Additional Paid-In Capital1,3841,3871,3901,3931,397
Retained Earnings (Accumulated Deficit)-1,416-1,417-1,404-1,390-1,379
Other Equity, Total00000
Total Equity-32-30-15319
Total Liabilities & Shareholders’ Equity127128139164176
Total Common Shares Outstanding1818181818
Last annual results 31/12/2024
Last interim results 31/03/2025
 
Fiscal period: Annual Fiscal period: Interim
Last fiscal year: 2024 Fiscal year: 2025
End of fiscal year: 31/12/2024 End of interim fiscal: 31/03/2025
Auditor name: Ernst & Young LLP Period length: -
Period length: -
Source: Reuters
Currency: USD
  • Latest update: -
Basic Factors
This service is only available to Patria Plus and Investor Plus subscribers. If you are a Patria Plus or Investor Plus client, please log in.
Economy Result Estimates
This service is only available to Patria Plus and Investor Plus subscribers. If you are a Patria Plus or Investor Plus client, please log in.